Global Information
회사소개 | 문의 | 위시리스트

중국의 항비만 처방약 시장 조사 보고서(2019년)

China Anti-Obesity Prescription Drugs Market Research Report 2019

리서치사 QYResearch
발행일 2019년 07월 상품 코드 895763
페이지 정보 영문 102 Pages
가격
US $ 3,400 ₩ 4,129,000 PDF by E-mail (Single User License)
US $ 5,100 ₩ 6,194,000 PDF by E-mail (Multi User License)
US $ 6,800 ₩ 8,259,000 PDF by E-mail (Enterprise Wide License)


중국의 항비만 처방약 시장 조사 보고서(2019년) China Anti-Obesity Prescription Drugs Market Research Report 2019
발행일 : 2019년 07월 페이지 정보 : 영문 102 Pages

중국의 항비만 처방약 시장은 예측기간 중 3.90%의 연평균 복합 성장률(CAGR)로 성장을 지속하여 2018년 5,520만 달러에서 2025년에는 7,253만 달러 규모에 달할 것으로 예측됩니다.

중국의 항비만 처방약(Anti-Obesity Prescription Drugs) 시장을 조사했으며, 시장 및 제품 개요, 판매량·매출·가격 등의 추이와 예측, 종류·용도·지역·기업별 상세 분석, 각종 시장 영향요인 분석, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

제1장 제품 범위

  • 제품 개요와 조사 대상
  • 시장 분석 : 제품 종류별
    • 판매량 비교
    • 시장 점유율
    • OTC
    • Rx
  • 시장 분석 : 용도 및 최종사용자별
    • 판매량·시장 점유율 비교
    • 원내 약국
    • 소매 약국
    • E-Commerce
  • 시장 분석 : 지역별
  • 판매량, 매출, 성장률
  • 거시지표

제2장 경쟁 환경과 제조업체

  • 판매량·시장 점유율
  • 매출·시장 점유율
  • 가격
  • 경쟁 구도와 동향
  • 제조거점, 설립일, 제품 유형

제3장 시장 추이 : 지역별

  • 판매량·점유율 추이
  • 매출·점유율 추이
  • 가격 추이

제4장 시장 추이 : 지역별

  • 판매량·점유율 추이
  • 매출·점유율 추이
  • 가격 추이
  • 판매량 성장률 추이

제5장 시장 추이 : 용도별

  • 판매량·점유율 추이
  • 판매량 성장률 추이

제6장 주요 제조업체 분석

  • Zhejiang Hisun
  • ZHIEN pharmaceutica
  • Lunan
  • Wanhan
  • Huadong Medicine
  • Roche

제7장 제조 비용 분석

  • 원재료 분석
  • 제조 비용 구조
  • 제조 프로세스

제8장 산업 체인, 조달 전략, 다운스트림(Downstream) 바이어

제9장 마케팅 전략 및 유통 판매업체

제10장 영향요인

  • 원재료 가격 동향
  • 수출입 동향

제11장 시장 예측

  • 판매량·매출 예측
  • 판매량 예측 : 종류별
  • 판매량 예측 : 용도별
  • 판매량 예측 : 지역별

제12장 조사결과와 결론

제13장 조사 방법 및 데이터 출처

LSH 19.08.09

This report studies the Anti-Obesity Prescription Drugs development status and future trend in China, focuses on top players in China, also splits Anti-Obesity Prescription Drugs by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The China Anti-Obesity Prescription Drugs market is valued at USD 55.20 million in 2018 and is expected to reach USD 72.53 million by the end of 2025, growing at a CAGR of 3.90% between 2019 and 2025.

The major players in global market include

Zhejiang Hisun

ZHIEN pharmaceutica

Lunan

Wanhan

Huadong Medicine

Roche

Other

Geographically, this report splits the China market into seven regions,

South China

East China

Southwest China

Northeast China

North China

Central China

Northwest China

On the basis of product, the Anti-Obesity Prescription Drugs market is primarily split into

OTC

Rx

On the basis on the end users/applications, this report covers

Hospitals Pharmacies

Retail Pharmacies

E-commerce

1 Anti-Obesity Prescription Drugs Overview 1

  • 1.1 Product Overview and Scope of Anti-Obesity Prescription Drugs 1
  • 1.2 Classification of Anti-Obesity Prescription Drugs by Product Category 2
    • 1.2.1 China Anti-Obesity Prescription Drugs Sales Comparison by Types (2014-2025) 2
    • 1.2.2 China Anti-Obesity Prescription Drugs Sales Market Share by Types in 2018 3
    • 1.2.3 OTC 4
    • 1.2.4 Rx 4
  • 1.3 China Anti-Obesity Prescription Drugs Market by Applications/End Users 5
    • 1.3.1 China Anti-Obesity Prescription Drugs Sales and Market Share Comparison by Applications (2014-2025) 5
    • 1.3.2 Hospitals Pharmacies 6
    • 1.3.3 Retail Pharmacies 7
    • 1.3.4 E-commerce 7
  • 1.4 China Anti-Obesity Prescription Drugs Market by Regions 8
    • 1.4.1 China Anti-Obesity Prescription Drugs Market Size (Million USD) Comparison by Regions (2014-2025) 8
    • 1.4.2 South China Anti-Obesity Prescription Drugs Status and Prospect (2014-2025) 8
    • 1.4.3 East China Anti-Obesity Prescription Drugs Status and Prospect (2014-2025) 9
    • 1.4.4 Southwest China Anti-Obesity Prescription Drugs Status and Prospect (2014-2025) 10
    • 1.4.5 Northeast China Anti-Obesity Prescription Drugs Status and Prospect (2014-2025) 11
    • 1.4.6 North China Anti-Obesity Prescription Drugs Status and Prospect (2014-2025) 12
    • 1.4.7 Central China Anti-Obesity Prescription Drugs Status and Prospect (2014-2025) 13
  • 1.5 China Market Size (Sales and Revenue) of Anti-Obesity Prescription Drugs (2014-2025) 14
    • 1.5.1 China Anti-Obesity Prescription Drugs Sales and Growth Rate (%) (2014-2025) 14
    • 1.5.2 China Anti-Obesity Prescription Drugs Revenue and Growth Rate (2014-2025) 14
  • 1.6 Macroscopic Indicator 16
    • 1.6.1 GDP for Major Regions 16
    • 1.6.2 Population and Labor Considered for Forecast 18
    • 1.6.3 Disposable Income Considered for Forecast 20

2 China Anti-Obesity Prescription Drugs Market Competition by Players/Manufacturers 22

  • 2.1 China Anti-Obesity Prescription Drugs Sales and Market Share of Key Players/Manufacturers (2018-2019) 22
  • 2.2 China Anti-Obesity Prescription Drugs Revenue and Share by Players/Manufacturers (2018-2019) 24
  • 2.3 China Anti-Obesity Prescription Drugs Average Price by Players/Manufacturers (2018-2019) 26
  • 2.4 China Anti-Obesity Prescription Drugs Market Competitive Situation and Trends 28
    • 2.4.1 China Anti-Obesity Prescription Drugs Market Concentration Ratec 28
    • 2.4.2 China Anti-Obesity Prescription Drugs Market Share of Top 3 and Top 5 Players/Manufacturers 29
    • 2.4.3 Mergers & Acquisitions, Expansion in China Market 30
  • 2.5 China Players/Manufacturers Anti-Obesity Prescription Drugs Headquarters, Established Date and Product Types 30

3 China Anti-Obesity Prescription Drugs Sales and Revenue by Regions (2014-2019) 32

  • 3.1 China Anti-Obesity Prescription Drugs Sales and Market Share by Regions (2014-2019) 32
  • 3.2 China Anti-Obesity Prescription Drugs Revenue and Market Share by Regions (2014-2019) 34
  • 3.3 China Anti-Obesity Prescription Drugs Price (USD/Unit) by Regions (2014-2019) 36

4 China Anti-Obesity Prescription Drugs Sales and Revenue by Type/ Product Category (2014-2019) 37

  • 4.1 China Anti-Obesity Prescription Drugs Sales and Market Share by Type/ Product Category (2014-2019) 37
  • 4.2 China Anti-Obesity Prescription Drugs Revenue (Million USD) and Market Share by Type (2014-2019) 39
  • 4.3 China Anti-Obesity Prescription Drugs Price (USD/Unit) by Type (2014-2019) 40
  • 4.4 China Anti-Obesity Prescription Drugs Sales Growth Rate by Type (2014-2019) 41

5 China Anti-Obesity Prescription Drugs Sales by Application (2014-2019) 42

  • 5.1 China Anti-Obesity Prescription Drugs Sales and Market Share by Applications (2014-2019) 42
  • 5.2 China Anti-Obesity Prescription Drugs Sales Growth Rate by Applications (2014-2019) 44

6 Analysis of Anti-Obesity Prescription Drugs Industry Key Manufacturers 45

  • 6.1 Zhejiang Hisun 45
    • 6.1.1 Company Profile 45
    • 6.1.2 Product Information 46
    • 6.1.3 Sales, Price, Revenue and Gross Margin 46
  • 6.2 ZHIEN pharmaceutica 47
    • 6.2.1 Company Profile 47
    • 6.2.2 Product Information 48
    • 6.2.3 Sales, Price, Revenue and Gross Margin 48
  • 6.3 Lunan 49
    • 6.3.1 Company Profile 49
    • 6.3.2 Product Information 50
    • 6.3.3 Sales, Price, Revenue and Gross Margin 50
  • 6.4 Wanhan 51
    • 6.4.1 Company Profile 51
    • 6.4.2 Product Information 52
    • 6.4.3 Sales, Price, Revenue and Gross Margin 52
  • 6.5 Huadong Medicine 53
    • 6.5.1 Company Profile 53
    • 6.5.2 Product Information 54
    • 6.5.3 Sales, Price, Revenue and Gross Margin 54
  • 6.6 Roche 55
    • 6.6.1 Company Profile 55
    • 6.6.2 Product Information 56
    • 6.6.3 Sales, Price, Revenue and Gross Margin 56

7 Anti-Obesity Prescription Drugs Manufacturing Cost Analysis 57

  • 7.1 Anti-Obesity Prescription Drugs Key Raw Materials Analysis 57
    • 7.1.1 Key Raw Materials 57
    • 7.1.2 Key Suppliers of Raw Materials 57
  • 7.2 Proportion of Manufacturing Cost Structure 58
    • 7.2.1 Raw Materials 58
    • 7.2.2 Labor Cost 59
    • 7.2.3 Other Costs Analysis 60
    • 7.2.4 Manufacturing Expenses 61
  • 7.3 Manufacturing Process Analysis of Anti-Obesity Prescription Drugs 62

8 Industrial Chain, Sourcing Strategy and Downstream Buyers 63

  • 8.1 Anti-Obesity Prescription Drugs Industrial Chain Analysis 63
  • 8.2 Upstream Raw Materials Sourcing 64
  • 8.3 Raw Materials Sources of Anti-Obesity Prescription Drugs Major Players/Manufacturers in 2018 64
  • 8.4 Downstream Buyers 65

9 Marketing Strategy Analysis, Distributors/Traders 66

  • 9.1 Marketing Channel 66
    • 9.1.1 Direct Marketing 68
    • 9.1.2 Indirect Marketing 68
    • 9.1.3 Marketing Channel Development Trend 68
  • 9.2 Market Positioning 69
    • 9.2.1 Pricing Strategy 69
    • 9.2.2 Brand Strategy 70
  • 9.3 Distributors/Traders List 71

10 Factors Influencing 73

  • 10.1 Price Trend of Key Industrial Raw Material 73
  • 10.2 Imports & Exports 74

11 China Anti-Obesity Prescription Drugs Market Size (Sales and Revenue) Forecast (2020-2025) 80

  • 11.1 China Anti-Obesity Prescription Drugs Sales, Revenue Forecast (2020-2025) 80
  • 11.2 China Anti-Obesity Prescription Drugs Sales Forecast by Type (2020-2025) 81
  • 11.3 China Anti-Obesity Prescription Drugs Sales Forecast by Application (2020-2025) 82
  • 11.4 China Anti-Obesity Prescription Drugs Sales Forecast by Regions (2020-2025) 83

12 Research Findings and Conclusion 86

13 Methodology and Data Source 87

  • 13.1 Methodology/Research Approach 87
    • 13.1.1 Research Programs/Design 87
    • 13.1.2 Market Size Estimation 88
    • 13.1.3 Market Breakdown and Data Triangulation 89
  • 13.2 Data Source 90
    • 13.2.1 Secondary Sources 90
    • 13.2.2 Primary Sources 91
  • 13.3 Author List 92
  • 13.4 Disclaimer 92
Back to Top
전화 문의
F A Q